Journal ArticleExpert Rev Hematol · December 30, 2025
INTRODUCTION: Fragmentation across operations, data systems, governance, and regulation leaves many blood supply networks ill-equipped to provide timely, equitable, and crisis-resilient transfusion support. Public health emergencies, such as COVID-19 and n ...
Full textLink to itemCite
Journal ArticleTrends Cancer · November 13, 2025
Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in refractory melanoma and durable responses in lung cancer. Glioblastoma presents distinct challenges for immunotherapy, including profound tumor heterogeneity, low T cell infiltration, ...
Full textLink to itemCite
ConferenceNeuro-Oncology · October 3, 2025
AbstractBACKGROUNDTumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in melanoma and is emerging as a promising mod ...
Full textCite
Journal ArticleCytotherapy · October 2025
BACKGROUND: The successful treatment of melanoma using autologous in vitro expanded tumor infiltrating lymphocytes (TILs) has sparked clinical trials for the assessment of TIL efficacy against other cancers, including non-small cell lung cancer (NSCLC). Th ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · June 16, 2025
The efficacy of T cell-activating therapies against glioma is limited by an immunosuppressive tumor microenvironment and tumor-induced T cell sequestration. We investigated whether peripherally infused nonantigen specific autologous lymphocytes could accum ...
Full textLink to itemCite
Journal ArticleJ Transl Med · May 6, 2025
BACKGROUND: Chimeric antigen receptor T-cell (CAR T-cell) therapies have shown significant promise in treating cancers and other diseases. However, the manufacturing processes for CAR T-cell therapies exhibit considerable variability, which can affect trea ...
Full textLink to itemCite
Journal ArticleRes Sq · April 25, 2025
Tumor-infiltrating lymphocyte (TIL) therapy, recently approved by the FDA for melanoma, is an emerging modality for cell-based immunotherapy. However, its application in immunologically "cold" tumors such as glioblastoma remains limited due to sparse T cel ...
Full textLink to itemCite
Journal ArticlebioRxiv · April 12, 2025
Tumor-infiltrating lymphocyte (TIL) therapy, recently approved by the FDA for melanoma, is an emerging modality for cell-based immunotherapy. However, its application in immunologically 'cold' tumors such as glioblastoma remains limited due to sparse T cel ...
Full textLink to itemCite
ConferenceNeuro-Oncology · November 11, 2024
AbstractWe have previously described the development of a novel brain bi-specific T cell engager (BRiTE) targeting EGFRvIII in Glioma. Despite BRiTEs impressive potency, efficacy in solid tumors is dependent ...
Full textCite
ConferenceBlood · November 5, 2024
Background: The availability of CAR-T (Chimeric Antigen Receptor T-cell) therapies is a pivotal advancement in cancer treatment. Local, or point-of-care, manufacturing addresses logistica ...
Full textCite
Journal ArticleLung Cancer · July 2024
BACKGROUND: Direct comparison of tumor microenvironment of matched lung cancer biopsies and pleural effusions (PE) from the same patients is critical in understanding tumor biology but has not been performed. This is the first study to compare the lung can ...
Full textLink to itemCite
ConferenceCytotherapy · June 2024
BACKGROUND AIMS: Culture-derived mesenchymal stromal cells (MSCs) exhibit variable characteristics when manufactured using different methods, source material and culture media. The purpose of this multicenter study was to assess the impact on MSC expansion ...
Full textLink to itemCite
Journal ArticleStem Cells Transl Med · May 14, 2024
BACKGROUND: Cord blood units (CBUs) that are ineligible for licensure due to incomplete compliance with FDA recommendations may be used for hematopoietic stem cell transplantation under urgent medical need and an Investigational Drug Application. The large ...
Full textLink to itemCite
Journal ArticleIntensive Care Med · March 2024
Haemorrhagic shock is frequent in critical care settings and responsible for a high mortality rate due to multiple organ dysfunction and coagulopathy. The management of critically ill patients with bleeding and shock is complex, and treatment of these pati ...
Full textLink to itemCite
Book · January 1, 2024
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, Fourth Edition continues to be the only "pocket-size" quick reference for pathology and transfusion medicine for residents and fellows. It is helpful to all physicians and allied health ...
Full textCite
Chapter · January 1, 2024
Albumin as compared with nonprotein colloid or crystalloid solutions has not been well addressed in appropriately designed studies. Thus, albumin administration is based on an individual patient's clinical status. Clinical situations where albumin is commo ...
Full textCite
Chapter · January 1, 2024
Cord blood (CB) is an alternative source of stem cells for hematopoietic and immunologic reconstitution of patients that do not have matched related donors. The functions of public CB banks include collection (CB harvesting, maternal consent, and evaluatio ...
Full textCite
Chapter · January 1, 2024
A safe, reliable, adequate, and available blood supply is critical to the function of complex healthcare systems worldwide. Blood transfusion is one of the most common therapeutic medical practices. The field of transfusion medicine (blood banking and tran ...
Full textCite
Journal ArticleStem Cells Transl Med · April 17, 2023
BACKGROUND: Treatment options for patients with COVID-19-related acute respiratory distress syndrome (ARDS) are desperately needed. Allogeneic human umbilical cord derived mesenchymal stromal cells (hCT-MSCs) have potential therapeutic benefits in these cr ...
Full textLink to itemCite
ConferenceCancer Research · April 4, 2023
AbstractGlioblastoma is the most prevalent primary brain malignancy, with a median survival of less than 21 months despite treatment with surgery, radiation, and chemotherapy. Significant intra-tumoral heter ...
Full textCite
Journal ArticlePLoS One · 2023
OBJECTIVE: To model the long-term clinical and economic outcomes of potential cord blood therapy in autism spectrum disorder (ASD). STUDY DESIGN: Markov microsimulation of ASD over the lifespan was used to compare two strategies: 1) standard of care (SOC), ...
Full textLink to itemCite
Chapter · January 1, 2023
Blood transfusion can be lifesaving and is currently the safest it has ever been. However, blood transfusion is associated with multiple adverse outcomes, including both noninfectious and infectious complications. Some mitigation strategies include donor t ...
Full textCite
Journal ArticleBlood · December 22, 2022
Although altruistic regular blood donors are vital for the blood supply, many become iron deficient from donation-induced iron loss. The effects of blood donation-induced iron deficiency on red cell transfusion quality or donor cognition are unknown. In th ...
Full textLink to itemCite
Journal ArticleHematology Am Soc Hematol Educ Program · December 9, 2022
The platelet collection and distribution system, based on volunteer nonremunerated donors, apheresis platelet collections, and primarily 1-directional distribution of platelets for up to 5-day room temperature storage at hospitals, typically performs well ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2022
BACKGROUND: A greater understanding of young, first-time donor motivators and barriers is needed to address the ongoing challenge of retaining these essential donors. STUDY DESIGN AND METHODS: Structured interviews conducted with 508 young, first-time whol ...
Full textLink to itemCite
ConferenceStem Cells Translational Medicine · September 6, 2022
AbstractIntroductionSARS-CoV-2 infection results in the COVID-19 disease that caused a global pandemic. In severe cases, COVID-19 lead ...
Full textCite
ConferenceStem Cells Translational Medicine · September 6, 2022
AbstractIntroductionDUOC-01 are microglia-like cells derived from umbilical cord blood CD14-positive monocytes, which have been shown ...
Full textCite
ConferenceStem Cells Translational Medicine · September 6, 2022
AbstractIntroductionCord blood (CB) is considered a human cell, tissue, and cellular-based product (HCT/P) by the U.S. Food and Drug A ...
Full textCite
ConferenceStem Cells Translational Medicine · September 6, 2022
AbstractIntroductionThe potency of mesenchymal stromal cells (MSCs) can be assessed by their ability to suppress proliferation of thir ...
Full textCite
Journal ArticleAnn Intern Med · September 2022
DESCRIPTION: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential treatment of COVID-19. However, meta-analysis data and recommendations are limited. The Association for the Advancement of Blood and Biotherapies (AABB) developed cl ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2022
BACKGROUND: Amotosalen/UVA pathogen-reduced platelet components (PRPCs) with storage up to 7 days are standard of care in France, Switzerland, and Austria. PRPCs provide effective hemostasis with reduced risk of transfusion-transmitted infections and trans ...
Full textLink to itemCite
Journal ArticleBlood · July 21, 2022
As the coronavirus disease (COVID-19) pandemic led to a global health crisis, there were limited treatment options and no prophylactic therapies for those exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Convalescent plasma is quick ...
Full textLink to itemCite
Journal ArticleVox Sang · July 2022
BACKGROUND AND OBJECTIVES: Donor eligibility questions and criteria for medical conditions vary between blood centres, suggesting that they are based more on local regulations or experience, rather than on published data, which are limited. As the donor po ...
Full textLink to itemCite
Chapter · January 1, 2022
Transfusion-associated graft-versus-host disease (TA-GVHD) is an uncommon yet almost always fatal complication of cellular blood component transfusion. The diagnosis of TA-GVHD is based on the characteristic clinical manifestations, pathological findings o ...
Full textCite
Chapter · January 1, 2022
Plasma and its derivatives are well-established clinical resources, but cost, risk of infectious disease transmission, although rare, and other adverse effects mandate their appropriate use. Continued investigation is warranted to clarify optimal and appro ...
Full textCite
Chapter · January 1, 2022
Pretransfusion testing includes ABO and Rhesus (Rh) type, and antibody screening to determine whether a patient has an unexpected red blood cell (RBC) antibody against a blood group antigen. If the antibody screen is positive, an identification panel is pe ...
Full textCite
Journal ArticleTransfusion · December 2021
BACKGROUND: Elevated fear and anxiety regarding donation-related stimuli (e.g., needles, pain, blood, fainting) has been associated with reduced blood donor recruitment and retention. The present longitudinal study tests the notion that this inverse relati ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2021
BACKGROUND: The potential for iron deficiency is a known blood donor health concern and suggests the need to inform donors about the potential risks of low iron levels as well as strategies to address these risks. STUDY DESIGN AND METHODS: Frequent (n = 90 ...
Full textLink to itemCite
Journal ArticlePLoS Med · December 2021
BACKGROUND: The United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent o ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2021
BACKGROUND: This study aimed to promote competence, autonomy, and relatedness among first-time whole blood donors to enhance intrinsic motivation and increase retention. STUDY DESIGN AND METHODS: Using a full factorial design, first-time donors (N = 2002) ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2021
BACKGROUND: The United States (US) leads all high-income countries in gunshot wound (GSW) deaths. However, previous US studies have not evaluated the national blood transfusion utilization patterns in hospitalized GSW patients. METHODS: Data from 2016 to 2 ...
Full textLink to itemCite
Journal ArticleTransfusion · July 2021
BACKGROUND: Minority RBC donors are important to support the transfusion needs of patients with sickle cell disease. Testing of donors for sickle cell trait (SCT) is performed to avoid transfusion of hemoglobin S+ (HbS+) RBCs to specific patient groups and ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · July 1, 2021
BACKGROUNDAlthough convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited.METHODSWe conducted a randomized, double-blind, controlled trial a ...
Full textLink to itemCite
Journal ArticleTransfusion · June 2021
BACKGROUND: Severe blood donor adverse events are rare, but due to their rarity studying them can be difficult. To get an accurate estimate of their frequency and rate in the donor population it may be necessary to combine donation data across countries. S ...
Full textLink to itemCite
Journal ArticleTransfusion · January 2021
BACKGROUND: Convalescent plasma (CP) for treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown preliminary signs of effectiveness in moderate to severely ill patients in reducing mortality. While studies have demonstrated a lo ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2020
BACKGROUND: With growing awareness of the prevalence of nonanemic iron deficiency among blood donors, there is a need to explore the extent of potential negative consequences. This study examined the relationship between various measures of iron status, bl ...
Full textLink to itemCite
Journal ArticleBlood · November 26, 2020
In this issue of Blood, Perreault et al showed decreasing total antibody levels over time in 15 repeat COVID-19 convalescent plasma (CCP) donors with at least 4 donations. The decrease was greatest between the final 2 time points reported, from days 70 to ...
Full textLink to itemCite
Journal ArticleTrials · November 17, 2020
An amendment to this paper has been published and can be accessed via the original article. ...
Full textLink to itemCite
Journal ArticleVox Sang · November 2020
BACKGROUND: This multi-national study evaluated changes in platelet (PLT) unit distributions at 12 national or regional blood collectors over a 10-year period. METHODS: Data on the total number of PLT distributions, the collection method, that is apheresis ...
Full textLink to itemCite
Journal ArticleTransfusion · October 2020
BACKGROUND: With improved safety of allogeneic blood supply, the use of preoperative autologous donations (PADs) and perioperative autologous cell salvage (PACS) has evolved. This study evaluated temporal trends in PAD and PACS use in the United States. ME ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2020
UNLABELLED: Risk assessments of transfusion-transmitted emerging infectious diseases (EIDs) are complicated by the fact that blood donors' demographics and behaviors can be different from the general population. Therefore, when assessing potential blood do ...
Full textLink to itemCite
Journal ArticleBMC Res Notes · August 6, 2020
OBJECTIVE: COVID19 has caused a global and ongoing pandemic. The need for population seroconversion data is apparent to monitor and respond to the pandemic. Using a lateral flow assay (LFA) testing platform, the seropositivity in 63 New York Blood Center ( ...
Full textLink to itemCite
Journal ArticleBlood · August 6, 2020
In the current issue of Blood, Xia et al evaluate the use of convalescent plasma for the treatment of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19)., SARS-CoV-2 has spurred a gl ...
Full textLink to itemCite
Journal ArticleTransfusion · July 2020
Since the beginning of the COVID-19 pandemic, the use of convalescent plasma as a possible treatment has been explored. Here we describe our experience as the first U.S. organization creating a COVID-19 convalescent plasma program to support its use throug ...
Full textLink to itemCite
Journal ArticleTransfusion · July 2020
BACKGROUND: Prior studies have shown donation-related fear to be associated with decreased donor confidence and an increased risk for vasovagal reactions. This study examined the effects of a predonation intervention that provided fearful donors with sugge ...
Full textLink to itemCite
Journal ArticleTrials · June 16, 2020
An amendment to this paper has been published and can be accessed via the original article. ...
Full textLink to itemCite
Journal ArticleTrials · June 8, 2020
OBJECTIVES: The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection. TRIAL DESIGN: This is a prospective, single-center, phase 2, randomized, controll ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · June 1, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven options for prophylaxis for those who have been exposed to SARS-CoV-2, nor ther ...
Full textLink to itemCite
Journal ArticleTransfusion · May 2020
Umbilical cord blood is an important cellular therapy product used for hematopoietic stem cell transplantation, but the US Food and Drug Administration guidance regarding donor screening to reduce the risk of Zika transmission has decreased the number of l ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · May 1, 2020
BACKGROUNDGlucose-6-phosphate dehydrogenase (G6PD) deficiency decreases the ability of red blood cells (RBCs) to withstand oxidative stress. Refrigerated storage of RBCs induces oxidative stress. We hypothesized that G6PD-deficient donor RBCs would have in ...
Full textLink to itemCite
Journal ArticlePediatrics · April 2020
BACKGROUND AND OBJECTIVES: Annual incidence of venous thromboembolism (VTE) including postoperative VTE in hospitalized children is rising significantly. A growing body of evidence supports the role of red blood cells (RBCs) in pathologic thrombosis. In th ...
Full textLink to itemCite
Journal ArticleAnesthesiology · March 2020
BACKGROUND: Group O erythrocytes and/or whole blood are used for urgent transfusions in patients of unknown blood type. This study investigated the impact of transfusing increasing numbers of uncrossmatched type O products on the recipient's first in-hospi ...
Full textLink to itemCite
Journal ArticleTransfusion · January 2020
BACKGROUND: This study examined the impact of age and sex of first-time donors who had not experienced an adverse event or deferral on their likelihood of and time to return. STUDY DESIGN AND METHODS: On behalf of the Biomedical Excellence for Safer Transf ...
Full textLink to itemCite
Journal ArticleVox Sang · November 2019
INTRODUCTION: In vitro qualitative differences exist in red cell concentrates (RCCs) units processed from whole blood (WB) depending on the method of processing. Minimal literature exists on differences in processing and variability in quality data. Theref ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2019
BACKGROUND: Contemporary population-based data on characteristics associated with blood donation in the United States (U.S.) are limited. STUDY DESIGN AND METHODS: A cross-sectional analysis was performed among 28,739 persons aged 18 years and older who pa ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2019
BACKGROUND: Interventions intended to motivate donors to return can be costly and time consuming. The current study examined the effect of a Web-based automated interview, informed by motivational interviewing and self-determination theory, on donor intent ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2019
BACKGROUND: Transfusion-related acute lung injury (TRALI) is a leading cause of transfusion-associated mortality for which multiple mitigation strategies have been implemented over the past decade. However, product-specific TRALI rates have not been report ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2019
BACKGROUND: The AABB compiles an annual synopsis of the published literature covering important developments in the field of transfusion medicine. An abridged version of this work is being made available in TRANSFUSION, with the full-length report availabl ...
Full textLink to itemCite
Journal ArticleBlood Transfus · July 2019
BACKGROUND: Despite fulfilling all requirements for blood donation, a large proportion of regular blood donors are iron deficient. Red blood cells (RBC) from iron-deficient donors may be particularly susceptible to damage induced by standard refrigerated s ...
Full textLink to itemCite
Journal ArticleTransfusion · July 2019
BACKGROUND: The chromium-51-labeled posttransfusion recovery (PTR) study has been the gold-standard test for assessing red blood cell (RBC) quality. Despite guiding RBC storage development for decades, it has several potential sources for error. METHODS: F ...
Full textLink to itemCite
Journal ArticleTransfusion · May 2019
BACKGROUND: Blood donation results in a loss of iron stores, which is particularly concerning for young female blood donors. This study examines the association of blood donation and iron deficiency among adolescent and adult females in the United States. ...
Full textLink to itemCite
Journal ArticleBlood · April 25, 2019
Blood transfusions are life-saving therapies; however, they can result in adverse events that can be infectious or, more commonly, noninfectious. The most common noninfectious reactions include febrile nonhemolytic transfusion reactions, allergic transfusi ...
Full textLink to itemCite
Journal ArticleTransfusion · April 2019
BACKGROUND: Some countries impose an upper age limit on whole blood and double RBC donation while others do not. We evaluated the safety of blood donation in older individuals (≥71 years), and their contribution to the blood supply of five countries. STUDY ...
Full textLink to itemCite
Journal ArticleTransfusion · February 2019
BACKGROUND: Demographic and hospital-level factors associated with red blood cell (RBC), plasma, and platelet transfusions in hospitalized patients across the U.S. are not well characterized. METHODS: We conducted a retrospective analysis of the National I ...
Full textLink to itemCite
Journal ArticleTransfusion · February 2019
BACKGROUND: ABO-incompatible platelet transfusions are common, and transfusions with ABO-incompatible plasma are increasing with the use of group A plasma and group O whole blood (WB) in emergencies. Many centers screen blood products for anti-A and/or ant ...
Full textLink to itemCite
Journal ArticleTransfusion · January 2019
BACKGROUND: Blood centers may offer point-based reward systems or cardiovascular disease (CVD) screening to incentivize donors. However, combining these incentives to improve CVD risk and blood donation rates has not been studied. STUDY DESIGN AND METHODS: ...
Full textLink to itemCite
Journal ArticleFront Microbiol · 2019
Zika virus (ZIKV) infection during pregnancy can cause significant problems, particularly congenital Zika syndrome. Nevertheless, the potential deleterious consequences and associated mechanisms of transfusion-transmitted ZIKV infection on pregnant individ ...
Full textLink to itemCite
Journal ArticleAging (Albany NY) · October 31, 2018
Aging is a major risk factor for many common and life-threatening pathologies. The development of reliable biomarkers of aging should lead to a better understanding of aging-associated processes and facilitate the development of therapeutic regimens that d ...
Full textLink to itemCite
Journal ArticleJAMA Surg · September 1, 2018
IMPORTANCE: Increasing evidence supports the role of red blood cells (RBCs) in physiological hemostasis and pathologic thrombosis. Red blood cells are commonly transfused in the perioperative period; however, their association with postoperative thrombotic ...
Full textLink to itemCite
ConferenceAm J Hypertens · July 16, 2018
BACKGROUND: Therapeutic apheresis is a term used to describe a group of treatments where blood components are separated in real time, and one component is removed, exchanged, and/or treated to remove pathogenic substances from the circulation. Plasma excha ...
Full textLink to itemCite
Journal ArticleJMIR Public Health Surveill · April 26, 2018
BACKGROUND: Increasing repeat blood donation behavior is a critical public health goal. According to self-determination theory, the process of developing internal motivation to give blood and an associated self-identity as a blood donor may be promoted by ...
Full textLink to itemCite
Journal ArticleTransfusion · April 2018
BACKGROUND: The AABB compiles an annual synopsis of the published literature covering important developments in the field of Transfusion Medicine. For the first time, an abridged version of this work is being made available in TRANSFUSION, with the full-le ...
Full textLink to itemCite
Journal ArticleTransfusion · April 2018
BACKGROUND: Platelets (PLTs) collected and stored in PLT additive solution Intersol (PAS-C) are presumed to reduce recipient exposure to donor plasma components; however, the effects of PAS-C on PLT supernatant composition are poorly defined. Therefore, we ...
Full textLink to itemCite
Journal ArticleTransfusion · April 2018
BACKGROUND: There are many influences on a hospital's demand for plasma. Pharmaceuticals are now being administered for many indications instead of plasma, although trauma resuscitation now emphasizes increased and early intervention with plasma. This mult ...
Full textLink to itemCite
Journal ArticleTransfusion · March 2018
BACKGROUND: Babesiosis is a potentially life-threatening zoonotic infection most frequently caused by the intraerythrocytic parasite Babesia microti. The pathogen is usually tickborne, but may also be transfusion or vertically transmitted. Healthy persons, ...
Full textLink to itemCite
Journal ArticleTransfusion · January 2018
BACKGROUND: The overall number of red blood cell (RBC) units distributed to hospitals throughout the world and in the United States has decreased lately. This study was performed to determine if the number of antigen-negative RBC units distributed to hospi ...
Full textLink to itemCite
Journal ArticleArch Pathol Lab Med · December 2017
CONTEXT: - Cytomegalovirus (CMV) can be transmitted by cellular blood products, leading to severe disease in immunosuppressed patients such as neonates and transplant recipients. To mitigate transfusion-transmitted CMV (TT-CMV), "CMV-safe" blood products ( ...
Full textLink to itemCite
Journal ArticleTransfusion · October 2017
BACKGROUND: Based on the hypothesis that self-determined motivation is associated with an increased likelihood of future behavior, the present study examined the ability of a motivational interview to promote internal motivation for giving blood and future ...
Full textLink to itemCite
Chapter · September 20, 2017
Consequent to refined donor selection and laboratory screening, blood transfusion in the United States is remarkably safe. Nonetheless, emerging and reemerging pathogens may pose risk to the blood supply, underscoring the need for ongoing vigilance and dev ...
Full textCite
Journal Article · September 15, 2017
BACKGROUNDIncreasing repeat blood donation behavior is a critical public health goal. According to self-determination theory, the process of developing internal motivation to give blood a ...
Full textCite
Journal ArticleTransfusion · September 2017
Zika virus (ZIKV) is a mosquito-borne flavivirus that is the focus of an ongoing pandemic. ZIKV is notable for its severe neurologic sequelae in babies born to infected mothers. High rates of subclinical infection, as evidenced by the finding of ZIKV RNA i ...
Full textLink to itemCite
Journal ArticleTransfusion · July 2017
BACKGROUND: To meet the needs of a diverse patient population, an adequate supply of red blood cells (RBCs) from ethnic/racial minority donors is essential. We previously described the 10-year changes in minority blood donation in the United States. This s ...
Full textLink to itemCite
Journal ArticleTransfusion · June 2017
BACKGROUND: Expanding the African American (AA) donor pool is critical to sustain transfusion support for sickle cell disease patients. STUDY DESIGN AND METHODS: The aims were to: 1) apply cognitive computing on donation related metrics to develop a predic ...
Full textLink to itemCite
Journal ArticleTransfusion · May 2017
BACKGROUND: To provide the appropriately diverse blood supply necessary to support alloimmunized and chronically transfused patients, minority donation recruitment programs have been implemented. This study investigated temporal changes in minority red blo ...
Full textLink to itemCite
Journal ArticleTransfusion · April 2017
BACKGROUND: Previous studies have reported a relationship between blood donation and decreased risk for cardiovascular events, and it has been proposed that this may be due to a lowering of blood pressure among hypertensive individuals who donate on a regu ...
Full textLink to itemCite
Journal ArticleTransfusion · March 2017
BACKGROUND: Zika virus (ZIKV) is transmitted by Aedes mosquitos and can result in severe congenital and adult neurologic abnormalities. ZIKV has rapidly spread northward through Central America and the Caribbean and autochthonous cases have been identified ...
Full textLink to itemCite
Journal ArticleVox Sang · February 2017
The use of di-ethylhexyl-phthalate (DEHP) in blood bags is under discussion due to toxicity concerns and possible restrictions. A questionnaire among 15 blood centres in nine countries showed that none so far have fully switched to non-DEHP blood bags. If ...
Full textLink to itemCite
Journal ArticleEmerg Infect Dis · February 2017
Over the past decade, West Nile virus (WNV) has spread across the United States. We aggregated blood donor data from 2010-2012 and then calculated the incidence of WNV RNA-positive donations and compared the incidence with neuroinvasive disease (NID) case ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · February 2017
The Blood Donor Competency, Autonomy, and Relatedness Enhancement (Blood Donor CARE) project was designed as a practical application of self-determination theory to encourage retention of first-time donors. Self-determination theory proposes that people ar ...
Full textLink to itemCite
Journal ArticleQual Life Res · February 2017
PURPOSE: Blood donors are considered to be one of the healthiest populations, but relatively little is known about their perceived quality of life. The objective was to examine HRQOL in donors infected with HIV, HBV, HCV or HTLV and a comparison group. MET ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · January 3, 2017
BACKGROUND: Some countries have limited the maximum allowable storage duration for red cells to 5 weeks before transfusion. In the US, red blood cells can be stored for up to 6 weeks, but randomized trials have not assessed the effects of this final week o ...
Full textLink to itemCite
ConferenceArch Pathol Lab Med · January 2017
CONTEXT: -Substantial variability between different antibody titration methods prompted development and introduction of uniform methods in 2008. OBJECTIVE: -To determine whether uniform methods consistently decrease interlaboratory variation in proficiency ...
Full textLink to itemCite
Journal ArticleTransfus Med Rev · January 2017
Zika virus (ZIKV), a mosquito-borne Flavivirus and emerging infectious disease, is the focus of an international public health emergency after its rapid spread through the Americas and the Caribbean. Although most ZIKV infections are subclinical or charact ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2016
BACKGROUND: Each unit of blood donated is processed and stored individually resulting in variability in the amount of red blood cells (RBCs) collected, RBC properties, and the 24-hour posttransfusion RBC survivability. As a result, each unit differs in its ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · December 2016
BACKGROUND: The loss of iron stores and resulting iron deficiency is well documented in whole blood or red blood cell donors. We hypothesized that relative iron deficiency also occurs as a result of more frequent platelet- and plasma-pheresis (apheresis) d ...
Full textLink to itemCite
Journal ArticleTransfusion · November 2016
BACKGROUND: The frequency of positive test results for transfusion-transmitted infections (TTIs) among blood donors is an important index of safety; thus, appropriate monitoring is critical, particularly when there are changes in policies affecting donor s ...
Full textLink to itemCite
Journal ArticleArch Pathol Lab Med · October 2016
CONTEXT: -Transfusion-associated graft-versus-host disease is a rare, often fatal complication of cellular blood product transfusion. The requirement that at-risk groups receive irradiated products reduces the incidence of transfusion-associated graft-vers ...
Full textLink to itemCite
Journal ArticleTransfus Apher Sci · August 2016
BACKGROUND: To alleviate the shortage of AB plasma, an alternative plasma product, low-titer group A plasma (LTGAP), is now available. The product is indicated for emergency transfusions when the patient's blood group has not been identified. The product's ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2016
BACKGROUND: As patient blood management becomes more widespread, fewer red blood cell (RBC) units have been transfused. This multinational study evaluated changes in blood center RBC distributions. STUDY DESIGN AND METHODS: Data on number and ABO and D gro ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2016
BACKGROUND: Differences in motivating factors that contribute to the decision to donate blood between infected and uninfected donors may help to identify areas for improving donor education. STUDY DESIGN AND METHODS: As part of a risk factor study, confirm ...
Full textLink to itemCite
Journal ArticleTransfusion · July 2016
BACKGROUND: Babesia microti is the foremost infectious risk to the US blood supply for which a Food and Drug Administration (FDA)-licensed test is unavailable for donation screening. Characterization of the antibody response to B. microti and correlation w ...
Full textLink to itemCite
Journal ArticleTransfusion · July 2016
BACKGROUND: The tick-borne pathogen Babesia microti has become recognized as the leading infectious risk associated with blood transfusion in the United States, yet no Food and Drug Administration-licensed screening tests are currently available to mitigat ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · June 2016
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing indications for the evidence-based use of therapeutic apheresis in human disease. Since the ...
Full textLink to itemCite
Journal ArticleTransfusion · June 2016
BACKGROUND: In contrast to standard donor retention strategies (e.g., mailings, phone calls, text messages), we developed a brief telephone interview, based on motivational interviewing principles, that encourages blood donors to reflect upon their unique ...
Full textLink to itemCite
Journal ArticlemBio · September 22, 2015
UNLABELLED: To investigate the transmission of novel infectious agents by blood transfusion, we studied changes in the virome composition of blood transfusion recipients pre- and posttransfusion. Using this approach, we detected and genetically characteriz ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2015
On March 25 and 26, 2015, the National Heart, Lung, and Blood Institute sponsored a meeting on the State of the Science in Transfusion Medicine on the National Institutes of Health (NIH) campus in Bethesda, Maryland, which was attended by a diverse group o ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2015
BACKGROUND: Apheresis platelet (AP) contamination may be influenced by manufacturing methods because bacteria are subject to the same forces that permit separation of blood cells. This study assesses whether apheresis technology influences in-process detec ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · September 2015
First-time blood donors are essential to the US donor pool, providing nearly a third of all donations. Unfortunately, there are a wide variety of obstacles to repeat donation and new donors are extremely difficult to retain. Because each donor experiences ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2015
BACKGROUND: Perioperative blood recovery (PBR) is an important component of patient blood management. We analyzed our experience providing PBR for community hospitals to determine procedure types and clinical variables associated with efficacy and cost-eff ...
Full textLink to itemCite
Journal ArticleTransfusion · May 2015
BACKGROUND: Risk factor surveillance among infected blood donors provides information on the effectiveness of eligibility assessment and is critical for reducing risk of transfusion-transmitted infection. STUDY DESIGN AND METHODS: American Red Cross, Blood ...
Full textLink to itemCite
Journal ArticleHealth Promot Pract · March 2015
INTRODUCTION: A pilot test of a computer-tailored intervention designed to promote blood donation among Blacks was conducted. METHOD: Intervention content, based on the transtheoretical model, offered participants individually and culturally tailored infor ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2014
BACKGROUND: Individuals with sickle cell disease (SCD), thalassemia, and leukemia often require frequent transfusion and run the risk of red blood cell (RBC) alloimmunization. To prevent alloimmunization or when alloimmunization is present, phenotype-match ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · December 2014
OBJECTIVE: The National Heart, Lung, and Blood Institute, of The National Institutes of Health, convened the 2012 State-of-the-Science Symposium in therapeutic apheresis (TA) with the goals of identifying and prioritizing future research concept proposals ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2014
BACKGROUND: Lack of ready access to a donation site may be a potential barrier to or influence the frequency of blood donations. In this study, we applied geographic analysis to blood donor behavior and use of different donation sites. STUDY DESIGN AND MET ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · November 4, 2014
Influenza viruses typically cause the most severe disease in children and elderly individuals. However, H1N1 viruses disproportionately affected middle-aged adults during the 2013-2014 influenza season. Although H1N1 viruses recently acquired several mutat ...
Full textLink to itemCite
Journal ArticleBlood · September 18, 2014
Human neutrophil antigen-3a (HNA-3a) antibodies contained in donor plasma can result in severe, sometimes fatal transfusion-related acute lung injury (TRALI). Recent developments in TRALI secondary to antibodies to HNA-3a antigen span diagnosis, pathophysi ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2014
BACKGROUND: Transfusion-transmitted babesiosis caused by Babesia microti has emerged as a significant risk to the US blood supply. This study estimated the prevalence of B. microti antibodies in blood donors using an investigational enzyme immunoassay (EIA ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2014
BACKGROUND: Plasma constituents have been implicated in some types of platelet (PLT) transfusion reactions. Leukoreduced apheresis PLTs stored in InterSol have 65% less plasma than apheresis PLTs stored in 100% plasma (PPs). This study compared transfusion ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2014
BACKGROUND: Evidence indicates that donor identity is an important predictor of donation behavior; however, prior studies have relied on diverse, unidimensional measures with limited psychometric support. The goals of this study were to examine the applica ...
Full textLink to itemCite
Journal ArticleTransfus Med Rev · July 2014
Hemolytic transfusion reactions due to red blood cell (RBC) alloantibodies are a leading cause of transfusion-associated death. In addition to reported deaths, RBC alloantibodies also cause significant morbidity in the form of delayed hemolytic transfusion ...
Full textLink to itemCite
Journal ArticleInjury · May 2014
INTRODUCTION: Newer studies have hypothesised about a coagulopathy that occurs early after trauma, early trauma induced coagulopathy, ETIC, and is defined by an elevated admission prothrombin time (PT). Also, referred to by some authors as acute traumatic ...
Full textLink to itemCite
Journal ArticleArch Pathol Lab Med · May 2014
CONTEXT: Advances in RHD genotyping offer an opportunity to update policies and practices for testing weak D phenotypes and administration of Rh immune globulin to postpartum women. OBJECTIVES: To repeat questions from a 1999 College of American Pathologis ...
Full textLink to itemCite
Journal ArticleTransfusion · March 2014
BACKGROUND: Babesia microti is the leading reported cause of red blood cell (RBC) transfusion-transmitted infection in the United States. Donor screening assays are in development. STUDY DESIGN AND METHODS: A decision analytic model estimated the cost-effe ...
Full textLink to itemCite
Journal ArticleTransfusion · March 2014
BACKGROUND: The Theory of Planned Behavior has been widely used in blood donation research, but the lack of uniform, psychometrically sound measures makes it difficult to draw firm conclusions or compare results across studies. Accordingly, the goal of thi ...
Full textLink to itemCite
Journal ArticleTransfusion · January 2014
The decision to treat a patient with therapeutic apheresis depends on multiple factors, such as what does the patient most likely have, is the diagnosis amenable to apheresis treatment, what is the harm-versus-benefit ratio of apheresis treatment in this p ...
Full textLink to itemCite
Journal ArticleBr J Anaesth · December 2013
Massive haemorrhage requires massive transfusion (MT) to maintain adequate circulation and haemostasis. For optimal management of massively bleeding patients, regardless of aetiology (trauma, obstetrical, surgical), effective preparation and communication ...
Full textLink to itemCite
Journal ArticleCurr Opin Hematol · November 2013
PURPOSE OF REVIEW: This review will address recent developments in the transfusion management of massively transfused trauma patients, focusing on the use of fixed blood component ratios in massive transfusion protocols. RECENT FINDINGS: The majority of tr ...
Full textLink to itemCite
Journal ArticleTransfus Apher Sci · October 2013
BACKGROUND AND OBJECTIVES: Some blood centers provide health screening as a public health measure and to encourage donation. The goal of the current study was to provide cardiovascular disease (CVD) screening to donors using high-throughput testing and web ...
Full textLink to itemCite
Journal ArticleTransfusion · October 2013
BACKGROUND: The past few decades have seen a resurgence of interest in leukapheresis products to improve the survival of infected patients with neutropenia. These products have a short shelf life and require donor stimulation with dexamethasone before coll ...
Full textLink to itemCite
ConferenceCan J Surg · October 2013
BACKGROUND: Massive transfusion protocols (MTPs) using high plasma and platelet ratios for exsanguinating trauma patients are increasingly popular. Major liver injuries often require massive resuscitations and immediate hemorrhage control. Current publishe ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · July 2013
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is charged with reviewing, updating and categorizating indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (Fourth Edition), the committee has incor ...
Full textLink to itemCite
Book · June 11, 2013
The second edition of Transfusion Medicine and Hemostasis continues to be the only "pocket-size" quick reference for pathology residents and transfusion medicine fellows. It covers all topics in blood banking, transfusion medicine, and clinical and laborat ...
Full textCite
Journal ArticleTransfusion · June 2013
BACKGROUND: Blacks have significantly lower blood donation rates than whites. Many views, experiences, and behaviors associated with blood donation are unique to black culture. Evidence suggests that culturally tailored health promotion programs help with ...
Full textLink to itemCite
Journal ArticleTransfusion · May 2013
BACKGROUND: Chagas disease is a parasitic infection by Trypanosoma cruzi, typically transmitted via infected triatomine bug fecal contamination of bite sites. Other routes of infection include congenital, oral, organ transplantation, and blood product tran ...
Full textLink to itemCite
Chapter · February 26, 2013
Transfusion-associated graft-versus-host disease (TA-GVHD) and transfusion-associated microchimerism (TA-MC) both result from the persistence of donor allogeneic leucocytes in transfusion recipients. TA-GVHD is a rare and highly fatal complication of cellu ...
Full textCite
Journal ArticleTransfus Apher Sci · February 2013
African American adults are half as likely to donate blood than whites. In order to understand this difference, African American and white participants completed a survey regarding demographics, medical and donation history, and motivators and barriers. Th ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2012
BACKGROUND: A uniform threshold strategy for converting from minipool (MP)-nucleic acid testing (NAT) to individual donation (ID)-NAT screening for acute West Nile virus (WNV) infection among blood donors is lacking. We report on WNV screening at the New Y ...
Full textLink to itemCite
Journal ArticleTransfusion · October 2012
BACKGROUND: Blood centers have implemented public health initiatives, including cardiovascular disease (CVD) screening, to improve donor and community health and serve as an incentive to donate. STUDY DESIGN AND METHODS: CVD risk screening and counseling w ...
Full textLink to itemCite
Journal ArticleAm Surg · June 2012
There are little data regarding the use of massive transfusion protocols (MTP) outside of the trauma setting. This study compares the use of an MTP between trauma and non-trauma (NT) patients. Data were collected for trauma and NT patients from the prospec ...
Link to itemCite
Journal ArticleTransfusion · June 2012
BACKGROUND: Massive transfusion protocols (MTPs) with fixed ratios of blood products may improve outcomes in coagulopathic adult trauma patients. However, there is a paucity of data on transfusion support protocols for pediatric trauma patients, whose mech ...
Full textLink to itemCite
Journal ArticleTransfusion · May 2012
BACKGROUND: The prevalence of blood donor eligibility factors has a major impact on the availability of blood donors and thus the blood supply in the United States. The prevalence of these factors may differ between demographic groups and thus help explain ...
Full textLink to itemCite
Journal ArticleAm J Hematol · May 2012
Neonatal alloimmune thrombocytopenia (NAIT) is the most common cause of severe thrombocytopenia and intracranial hemorrhage in the perinatal period. While the gold standard for making a diagnosis of NAIT is detection of a human platelet antigen (HPA)-speci ...
Full textLink to itemCite
Journal ArticleJ Trauma Acute Care Surg · April 2012
BACKGROUND: Damage control resuscitation (DCR) has improved outcomes in severely injured patients. In civilian centers, massive transfusion protocols (MTPs) represent the most formal application of DCR principles, ensuring early, accurate delivery of high ...
Full textLink to itemCite
Journal ArticleJ Pediatr · February 2012
OBJECTIVE: To evaluate coagulopathy in pediatric trauma patients on presentation to the emergency department, and to quantify the relationship with mortality. STUDY DESIGN: Pediatric trauma patients requiring a blood transfusion (red blood cells, fresh fro ...
Full textLink to itemCite
Journal ArticleTransfusion · January 2012
The focus of this study was to determine if there is significant data to prohibit short-term storage of red blood cells (RBCs; i.e., <24 hr) at 1 to 10°C rather than 1 to 6°C, which occurs not uncommonly when RBCs are stored in a cooler for a patient durin ...
Full textLink to itemCite
Journal ArticleTransfus Med Rev · January 2012
Blood centers have a central role in the community through recruitment and donation, and these community interactions enable blood centers to have a critical role in public health. Some public health initiatives are inherent in the blood center, such as pr ...
Full textLink to itemCite
Journal ArticleAm Surg · August 2011
Despite conflicting data regarding its effectiveness, many massive transfusion protocols (MTPs) include recombinant Factor VIIa (rFVIIa) as an adjunct to hemorrhage control. Over a 3-year period, outcome data for massively transfused patients was compared ...
Link to itemCite
Journal ArticleJ Trauma · June 2011
BACKGROUND: Trauma patients present with a coagulopathy, termed early trauma-induced coagulopathy (ETIC), that is associated with increased mortality. This study investigated hemostatic changes responsible for ETIC. METHODS: Case-control study of trauma pa ...
Full textLink to itemCite
Journal ArticleJ Natl Med Assoc · April 2011
BACKGROUND: Nationally, minorities are underrepresented in community blood donation programs. The reason for this disparity is poorly understood. To better understand why minorities do not donate, first, accurate blood donor and donation data are needed. M ...
Full textLink to itemCite
Journal ArticleCan J Surg · April 2011
BACKGROUND: Early transfusion of blood products for severely injured patients can improve volume depletion, acidosis, dilution and coagulopathy. There is concern that some patients are unnecessarily exposed to the risks of emergent transfusion with uncross ...
Full textLink to itemCite
Journal ArticleMinerva Anestesiol · March 2011
Massive transfusion is an essential part of resuscitation efforts in acute trauma patients. The goal is to quickly correct trauma-induced coagulopathy and replace red blood cell (RBC) mass with the minimal number as well as the appropriate choice of blood ...
Link to itemCite
Journal ArticleBlood · February 3, 2011
Over the past 60 years, the transfusion medicine community has attained significant knowledge regarding transfusion-related acute lung injury (TRALI) through the bedside to bench and back to the bedside model. First, at the bedside, TRALI causes hypoxia an ...
Full textLink to itemCite
Journal ArticleTransfusion · January 2011
BACKGROUND: Historically, African Americans have a general mistrust for the health care system that has contributed to significant health disparities. The goal of this study was to evaluate whether this distrust among African Americans affects attitudes to ...
Full textLink to itemCite
Journal ArticleJ Pediatr · December 2010
OBJECTIVE: To test the hypothesis that red blood cell (RBC) transfusions increase the risk of necrotizing enterocolitis (NEC) in premature infants, we investigated whether the risk of "transfusion-associated" NEC is higher in infants with lower hematocrits ...
Full textLink to itemCite
Journal ArticleCurr Opin Hematol · November 2010
PURPOSE OF REVIEW: In the United States, blood donation rates of African-Americans are 25-50% of that of white individuals. As African-Americans make up an ever increasing and now substantial minority, and African-American recipients of blood transfusion, ...
Full textLink to itemCite
Journal ArticleTransfusion · June 2010
BACKGROUND: In the United States, African Americans donate at approximately half the rate of whites and therefore are underrepresented in the volunteer blood donor pool. The goal of this study was to identify motivators and barriers to African Americans do ...
Full textLink to itemCite
Journal ArticleTransfusion · April 2010
BACKGROUND: Presenting blood donors are screened to ensure both their safety and that of the recipients of blood products. Donors with identified risks are deferred from donating blood either temporarily or permanently. Minorities are underrepresented as d ...
Full textLink to itemCite
Journal ArticleTransfusion · February 2010
BACKGROUND: Recent data from military and civilian centers suggest that mortality is decreased in massive transfusion patients by increasing the transfusion ratio of plasma and platelet (PLT) products, and fibrinogen in relationship to red blood cell (RBC) ...
Full textLink to itemCite
Journal ArticleJ Trauma · February 2010
BACKGROUND: Early prediction of the need for massive transfusion (MT) remains difficult. We hypothesized that MT protocol (MTP) utilization would improve by identifying markers for MT (>10 units packed red blood cell [PRBC] in 24 hours) in torso gunshot wo ...
Full textLink to itemCite
Chapter · January 1, 2010
Introduction In the USA, blood transfusion is the most common procedure performed in hospitals [1]. Component therapy is the preferred method of blood administration, as it allows blood transfusion to be individualized to the patient's specific needs. Bloo ...
Full textCite
Journal ArticleJ Clin Apher · 2010
The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (fourth edition), the subcommittee has incorporated ...
Full textLink to itemCite
Chapter · December 1, 2009
This chapter discusses the other types of blood group systems, collections and their antigens. The blood group systems include Chido/Rogers blood group system, Colton blood group system, Cromer blood group system and Diego blood group system among others. ...
Full textCite
Chapter · December 1, 2009
This chapter gives an account of albumin and its related products. Albumin is the most abundant protein in human plasma comprising of 50-60% of the total plasma protein and accounts for 80-85% of the osmotic pressure of plasma and therefore maintains and r ...
Full textCite
Chapter · December 1, 2009
This chapter discusses massive transfusion which is commonly defined as transfusion of 10 or more red blood cell (RBC) products within 24 hours, which approximates the total blood volume of an adult recipient. Massive transfusion can occur in a variety of ...
Full textCite
Chapter · December 1, 2009
This chapter gives an account of the treatment procedure known as LDL pheresis. It involves the removal of apo-B-containing low density lipoprotein (LDL) and lipoprotein(a) [Lp(a)]. LDL pheresis is indicated in the treatment of familial hypercholesterolemi ...
Full textCite
Chapter · December 1, 2009
This chapter discusses transfusion in perinatal medicine. Transfusion management of the pregnant woman and fetus requires special consideration and this chapter address the related issues: routine prenatal and neonatal transfusion testing in relationship t ...
Full textCite
Chapter · December 1, 2009
This chapter discusses human immunoglobulin (Ig) and its preparations. Human immunoglobulins are commonly prepared from large pools of whole blood or apheresis derived plasma and are typically referred to as plasma derivatives. Ig preparations are concentr ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on the therapeutic procedure known as therapeutic erythrocytaphereis. Therapeutic erythrocytapheresis is also known as red blood cell exchange and this procedure involves the removal of whole blood and passing it through a medical devi ...
Full textCite
Chapter · December 1, 2009
This chapter discusses graft versus host diseases associated with transfusion (TA-GVHD). Transfusion associated graft versus host disease are rare and almost universally fatal complication of blood product transfusion. The disease occurs due to the co-tran ...
Full textCite
Chapter · December 1, 2009
This chapter discusses therapeutic plasma exchange (TPE) also known as plasmapheresis. Therapeutic plasma exchange is a therapeutic procedure in which the blood of the patient is removed and passed through a medical device that separates out and removes th ...
Full textCite
Chapter · December 1, 2009
This chapter discusses therapeutic thrombocytapheresis which involves the removal of platelet from patients with thrombocytosis, who have a platelet count of >500,000/μl. Thrombocytosis can be a primary disorder occurring as a result of myeloproliferative ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on therapeutic phlebotomy which involves the therapeutic removal of whole blood, in order to decrease abnormally elevated iron stores or red blood cell (RBC) mass. In patients with erythrocytosis, phlebotomy decreases the blood viscosi ...
Full textCite
Chapter · December 1, 2009
This chapter discusses platelet products that include those manufactured from whole blood and those manufactured by apheresis. Platelets are an essential component of hemostasis and deficiencies in platelet number or function can result in bleeding and hem ...
Full textCite
Chapter · December 1, 2009
This chapter describes identification of antibodies in blood products. Unexpected RBC antibodies are found in 1.2% to 35% of the population and initial detection of RBC alloantibodies can occur when testing the patient's plasma for ABO type, antibody scree ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the Kell and Kidd systems of blood group. The Kell and Kidd blood group systems antigens are carried on red blood cells (RBC) membrane glycoproteins. Antibodies to the Kell and Kidd blood group antigens can cause hemolytic transfusio ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the metabolic, hypotensive and other acute reactions an complications of transfusion. Metabolic complications of blood transfusion are most often seen in neonates or in circumstances in which large volumes of blood products are trans ...
Full textCite
Chapter · December 1, 2009
This chapter discusses washing of blood products during processing of the blood product. Washing refers to the process that removes the non-cellular fluid in RBC, platelet and other products and replaces it typically with saline. This procedure removes mor ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on frozen blood products and the various methods use in the process. Blood products are frozen in order to lengthen their storage time and RBC products are cryopreserved in glycerol, which must be removed prior to transfusion. Currentl ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the management of hemoglobinopathy patients with transfusion. The patients with hemoglobinopathies require special considerations due to several reasons: they require acute and chronic, simple and exchange transfusions, need phenotyp ...
Full textCite
Chapter · December 1, 2009
This chapter describes the management of blood during surgery. Blood management refers to the practice of minimizing allogeneic blood use, while maximizing patient outcome. Blood management has four main points: a focus on guideline-driven proper use of ba ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the process of irradiation of blood products. Irradiation of blood products is performed to abrogate the risk of transfusion associated graft verses host disease (TA-GVHD) which is a rare and almost fatal complication of blood transf ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on the methods for detection of bacterial contamination of blood products and with emphasis on platelet products. Various methods are described for avoiding bacterial contamination such as donor screening, methods to reduce bacterial c ...
Full textCite
Chapter · December 1, 2009
This chapter gives a review of Rh immune globulin (RhIg). The RhIg is mentioned to be a human-plasma derived product consisting of IgG antibodies to the D antigen and is most commonly used to prevent immunization to the D antigen in D-negative individuals ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the ABO and H blood group system. The ABO blood group system consists of the A; B; A,B and A antigens and anti-A and anti-B antibodies are mentioned to be most clinically significant in transfusion practice. These reciprocal antibodi ...
Full textCite
Chapter · December 1, 2009
This chapter gives an overview of therapeutic apheresis (TA). Therapeutic apheresis involves the removal of whole blood from a patient, separation of the whole blood into one or more fractions, followed by the removal of the indicated fraction which will b ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on the Rh blood group system and this system is second to the ABO system in clinical importance because of the Rh antigens. The Rh antigens are highly immunogenic and the corresponding antibodies can result in hemolytic transfusion rea ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the therapeutic procedure known as immunoadsorption (IA). Immunoadsorption utilizes columns that adsorb out immunoglobulin (Ig) by their binding to Staphylococcal protein A and this protein has a high affinity for the Fc portion of I ...
Full textCite
Chapter · December 1, 2009
This chapter describes the therapeutic procedure called leukapheresis or leukocytapheresis. This procedure involves the removal of white blood cells (WBCs) from patients with hyperleukocytosis, defined as a circulating WBC or leukemic blast cell count >100 ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the tests required before the blood transfusion. Pretransfusion testing includes the immunohematologic testing needed for proper patient blood typing, component selection and compatibility testing, in order to ensure optimal patient ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on transfusion-associated microchimeism (TA-MC). Chimerism is the presence of more than one genetically distinct population of cells in a single organism that originated from more than one zygote and microchimerism occurs when the non- ...
Full textCite
Chapter · December 1, 2009
This chapter describes the direct antiglobulin test (DAT) which is also known as Direct Coombs test (DCT). The test detects the presence of immunoglobulin G (IgG) or complement C3 and small amounts of IgG and complement are found on red blood cells (RBCs) ...
Full textCite
Chapter · December 1, 2009
This chapter discusses the various diseases transmitted by blood transfusion. This transfusion transmitted diseases (TTD) can be caused by viruses, protozoa and prions. The mitigation of transfusion transmission of infectious agents is mentioned to be base ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on the role of the hospital transfusion service (TS) physician. The physician plays a leading role in a critical operation within the hospital by ensuring a reliable and adequate supply of safe and effective blood products and matching ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on the blood product, cryoprecipitate, its indications, preparation and administration. Cryoprecipitate or cryo is also known as Cryoprecipitated Antihemophilic Factor (AHF) and it is made from human plasma. When fresh frozen plasma (F ...
Full textCite
Chapter · December 1, 2009
This chapter discusses allergic, anaphylactoid and anaphylactic reactions following blood transfusion. Allergic reactions can occur following blood transfusion, and are the result of an interaction between an allergen and preformed antibody, usually IgF. T ...
Full textCite
Chapter · December 1, 2009
This chapter reviews autoimmune hemolytic anemias (AIHA) which includes a group of disorders where autoantibodies are directed against red blood cell (RBC) membrane antigens. This results in shortened RBC survival through activation of the complement syste ...
Full textCite
Chapter · December 1, 2009
This chapter gives a review of the Lewis, I and P blood group systems. The antigens in the Lewis blood group systems are composed of terminal carbohydrate moieties added to protein or lipid backbones in a configuration similar to that of the ABO antigens. ...
Full textCite
Chapter · December 1, 2009
This chapter focuses on the MNS blood group system and the Duffy blood group systems. The MNS blood group system consists of the antigens M, N, S, s and U, which are determinants on glycophorins A and B and antibodies to these antigens can be clinically si ...
Full textCite
Journal ArticleTransfus Apher Sci · December 2009
BACKGROUND: An adequate blood supply depends on volunteer non-remunerated blood donors. African Americans have lower blood donation rates than whites. To improve African American blood donation rates, the motivators and barriers to African Americans must b ...
Full textLink to itemCite
Journal ArticleTransfusion · October 2009
BACKGROUND: Historically, minority populations have represented only a small proportion of US blood donors, but recent trends in immigration and potential blood shortages emphasize the need for recruitment strategies to increase minority donations. STUDY D ...
Full textLink to itemCite
Journal ArticleArch Pathol Lab Med · September 2009
CONTEXT: Nationally, African Americans are underrepresented in community blood donation programs. To increase blood donation by African Americans, differences between motivators and barriers to blood donation between races should be investigated. OBJECTIVE ...
Full textLink to itemCite
Journal ArticleTransfusion · August 2009
BACKGROUND: Storage of red blood cells (RBCs) is necessary for an adequate blood supply. However, reports have identified potential negative sequelae of transfusing stored RBCs. An animal model would be useful to investigate the pathophysiology of transfus ...
Full textLink to itemCite
Book · June 8, 2009
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, Third Edition, is the only pocket-sized, quick reference for pathology and transfusion medicine residents and fellows. It covers all topics in transfusion medicine and clinical and labor ...
Cite
Chapter · June 8, 2009
This chapter discusses the Kell and Kidd systems of blood group. The Kell and Kidd blood group systems antigens are carried on red blood cells (RBC) membrane glycoproteins. Antibodies to the Kell and Kidd blood group antigens can cause hemolytic transfusio ...
Full textCite
Chapter · June 8, 2009
This chapter discusses graft versus host diseases associated with transfusion (TA-GVHD). Transfusion associated graft versus host disease are rare and almost universally fatal complication of blood product transfusion. The disease occurs due to the co-tran ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the other types of blood group systems, collections and their antigens. The blood group systems include Chido/Rogers blood group system, Colton blood group system, Cromer blood group system and Diego blood group system among others. ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on the blood product, cryoprecipitate, its indications, preparation and administration. Cryoprecipitate or cryo is also known as Cryoprecipitated Antihemophilic Factor (AHF) and it is made from human plasma. When fresh frozen plasma (F ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the tests required before the blood transfusion. Pretransfusion testing includes the immunohematologic testing needed for proper patient blood typing, component selection and compatibility testing, in order to ensure optimal patient ...
Full textCite
Chapter · June 8, 2009
This chapter describes identification of antibodies in blood products. Unexpected RBC antibodies are found in 1.2% to 35% of the population and initial detection of RBC alloantibodies can occur when testing the patient's plasma for ABO type, antibody scree ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the therapeutic procedure known as immunoadsorption (IA). Immunoadsorption utilizes columns that adsorb out immunoglobulin (Ig) by their binding to Staphylococcal protein A and this protein has a high affinity for the Fc portion of I ...
Full textCite
Chapter · June 8, 2009
This chapter describes the management of blood during surgery. Blood management refers to the practice of minimizing allogeneic blood use, while maximizing patient outcome. Blood management has four main points: a focus on guideline-driven proper use of ba ...
Full textCite
Chapter · June 8, 2009
This chapter gives an account of albumin and its related products. Albumin is the most abundant protein in human plasma comprising of 50-60% of the total plasma protein and accounts for 80-85% of the osmotic pressure of plasma and therefore maintains and r ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on frozen blood products and the various methods use in the process. Blood products are frozen in order to lengthen their storage time and RBC products are cryopreserved in glycerol, which must be removed prior to transfusion. Currentl ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on the MNS blood group system and the Duffy blood group systems. The MNS blood group system consists of the antigens M, N, S, s and U, which are determinants on glycophorins A and B and antibodies to these antigens can be clinically si ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on transfusion-associated microchimeism (TA-MC). Chimerism is the presence of more than one genetically distinct population of cells in a single organism that originated from more than one zygote and microchimerism occurs when the non- ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on therapeutic phlebotomy which involves the therapeutic removal of whole blood, in order to decrease abnormally elevated iron stores or red blood cell (RBC) mass. In patients with erythrocytosis, phlebotomy decreases the blood viscosi ...
Full textCite
Chapter · June 8, 2009
This chapter gives a review of the Lewis, I and P blood group systems. The antigens in the Lewis blood group systems are composed of terminal carbohydrate moieties added to protein or lipid backbones in a configuration similar to that of the ABO antigens. ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on the therapeutic procedure known as therapeutic erythrocytaphereis. Therapeutic erythrocytapheresis is also known as red blood cell exchange and this procedure involves the removal of whole blood and passing it through a medical devi ...
Full textCite
Chapter · June 8, 2009
This chapter gives an overview of therapeutic apheresis (TA). Therapeutic apheresis involves the removal of whole blood from a patient, separation of the whole blood into one or more fractions, followed by the removal of the indicated fraction which will b ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the process of irradiation of blood products. Irradiation of blood products is performed to abrogate the risk of transfusion associated graft verses host disease (TA-GVHD) which is a rare and almost fatal complication of blood transf ...
Full textCite
Chapter · June 8, 2009
This chapter gives a review of Rh immune globulin (RhIg). The RhIg is mentioned to be a human-plasma derived product consisting of IgG antibodies to the D antigen and is most commonly used to prevent immunization to the D antigen in D-negative individuals ...
Full textCite
Chapter · June 8, 2009
This chapter discusses human immunoglobulin (Ig) and its preparations. Human immunoglobulins are commonly prepared from large pools of whole blood or apheresis derived plasma and are typically referred to as plasma derivatives. Ig preparations are concentr ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the metabolic, hypotensive and other acute reactions an complications of transfusion. Metabolic complications of blood transfusion are most often seen in neonates or in circumstances in which large volumes of blood products are trans ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the management of hemoglobinopathy patients with transfusion. The patients with hemoglobinopathies require special considerations due to several reasons: they require acute and chronic, simple and exchange transfusions, need phenotyp ...
Full textCite
Chapter · June 8, 2009
This chapter reviews autoimmune hemolytic anemias (AIHA) which includes a group of disorders where autoantibodies are directed against red blood cell (RBC) membrane antigens. This results in shortened RBC survival through activation of the complement syste ...
Full textCite
Chapter · June 8, 2009
This chapter discusses washing of blood products during processing of the blood product. Washing refers to the process that removes the non-cellular fluid in RBC, platelet and other products and replaces it typically with saline. This procedure removes mor ...
Full textCite
Chapter · June 8, 2009
This chapter discusses allergic, anaphylactoid and anaphylactic reactions following blood transfusion. Allergic reactions can occur following blood transfusion, and are the result of an interaction between an allergen and preformed antibody, usually IgF. T ...
Full textCite
Chapter · June 8, 2009
This chapter discusses platelet products that include those manufactured from whole blood and those manufactured by apheresis. Platelets are an essential component of hemostasis and deficiencies in platelet number or function can result in bleeding and hem ...
Full textCite
Chapter · June 8, 2009
This chapter discusses transfusion in perinatal medicine. Transfusion management of the pregnant woman and fetus requires special consideration and this chapter address the related issues: routine prenatal and neonatal transfusion testing in relationship t ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on the methods for detection of bacterial contamination of blood products and with emphasis on platelet products. Various methods are described for avoiding bacterial contamination such as donor screening, methods to reduce bacterial c ...
Full textCite
Chapter · June 8, 2009
This chapter discusses therapeutic plasma exchange (TPE) also known as plasmapheresis. Therapeutic plasma exchange is a therapeutic procedure in which the blood of the patient is removed and passed through a medical device that separates out and removes th ...
Full textCite
Chapter · June 8, 2009
This chapter discusses massive transfusion which is commonly defined as transfusion of 10 or more red blood cell (RBC) products within 24 hours, which approximates the total blood volume of an adult recipient. Massive transfusion can occur in a variety of ...
Full textCite
Chapter · June 8, 2009
This chapter describes the therapeutic procedure called leukapheresis or leukocytapheresis. This procedure involves the removal of white blood cells (WBCs) from patients with hyperleukocytosis, defined as a circulating WBC or leukemic blast cell count >100 ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on the Rh blood group system and this system is second to the ABO system in clinical importance because of the Rh antigens. The Rh antigens are highly immunogenic and the corresponding antibodies can result in hemolytic transfusion rea ...
Full textCite
Chapter · June 8, 2009
This chapter gives an account of the treatment procedure known as LDL pheresis. It involves the removal of apo-B-containing low density lipoprotein (LDL) and lipoprotein(a) [Lp(a)]. LDL pheresis is indicated in the treatment of familial hypercholesterolemi ...
Full textCite
Chapter · June 8, 2009
This chapter focuses on the role of the hospital transfusion service (TS) physician. The physician plays a leading role in a critical operation within the hospital by ensuring a reliable and adequate supply of safe and effective blood products and matching ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the various diseases transmitted by blood transfusion. This transfusion transmitted diseases (TTD) can be caused by viruses, protozoa and prions. The mitigation of transfusion transmission of infectious agents is mentioned to be base ...
Full textCite
Chapter · June 8, 2009
This chapter discusses therapeutic thrombocytapheresis which involves the removal of platelet from patients with thrombocytosis, who have a platelet count of >500,000/μl. Thrombocytosis can be a primary disorder occurring as a result of myeloproliferative ...
Full textCite
Chapter · June 8, 2009
This chapter discusses the ABO and H blood group system. The ABO blood group system consists of the A; B; A,B and A antigens and anti-A and anti-B antibodies are mentioned to be most clinically significant in transfusion practice. These reciprocal antibodi ...
Full textCite
Chapter · June 8, 2009
This chapter describes the direct antiglobulin test (DAT) which is also known as Direct Coombs test (DCT). The test detects the presence of immunoglobulin G (IgG) or complement C3 and small amounts of IgG and complement are found on red blood cells (RBCs) ...
Full textCite
Journal ArticleTransfusion · June 2009
BACKGROUND: A variable effect of inflammation on alloimmunization to transfused red blood cells (RBCs) in mice has been recently reported. We investigated whether RBC alloimmunization in humans was affected by transfusion of blood products in temporal prox ...
Full textLink to itemCite
Journal ArticleAnesth Analg · June 2009
The management of massively transfused trauma patients has improved with a better understanding of trauma-induced coagulopathy, the limitations of crystalloid infusion, and the implementation of massive transfusion protocols (MTPs), which encompass transfu ...
Full textLink to itemCite
Journal ArticleJ Trauma · June 2009
INTRODUCTION: Transfusion practices across the country are changing with aggressive use of plasma (fresh-frozen plasma [FFP]) and platelets during massive transfusion with current military recommendations to use component therapy at a 1:1:1 ratio of packed ...
Full textLink to itemCite
Journal ArticleTransfusion · June 2009
BACKGROUND: Blood donation is a medical procedure with attendant risks, and thus blood donors should undergo acceptable informed consent. There are no guidelines for the informed consent forms (ICFs) for whole blood donors or for parental consent forms (PC ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · 2009
Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine "hypersensitivity." When schistocytes are present it is frequently termed "quinine-associated TTP/HUS." A severe deficiency of the vWF-cleaving protease, ADA ...
Full textLink to itemCite
Book · January 1, 2009
This new handbook in transfusion medicine and hemostasis aims to combine clinical and laboratory information from two fields which have high degrees of overlap into one concise, easy-to-use pocket book. This comprehensive reference guide will have the dept ...
Full textCite
Journal ArticleTransfus Med Rev · July 2008
Unique issues in blood donation and blood transfusion regarding African Americans (AA) in the United States span the donation process, manufacturing of products, and hospital transfusion service. As AAs become a growing population, a constant supply of blo ...
Full textLink to itemCite
Journal ArticleTransfus Med Rev · April 2008
Nucleic acid-based technology is now at a point where the field of transfusion medicine is ready for its widespread application. In the donor center, genotyping of red blood cell (RBC) products provides phenotype-matched products for special patient popula ...
Full textLink to itemCite
Journal ArticleAm J Hematol · March 2008
Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy. Limited data are available regarding repeat HIT antibody testing after an initial negative test. We conducted a retrospective study to determine the utility of repeat test ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · June 2007
The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned o ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · June 2007
The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. This elaborate process had been undertaken every 7 years resulting in three prior publications ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · June 2007
The American Society for Apheresis (ASFA) Apheresis Applications Committee is responsible for a review and categorization of indications for therapeutic apheresis. The results of the review process were previously published in 1986, 1993, and 2000 as the A ...
Full textLink to itemCite
Journal ArticleTransfusion · June 2006
BACKGROUND: To improve donor management for donor lymphocyte collections, a protocol was established to tailor the amount of whole blood processed during leukapheresis to achieve the requested cellular dose. STUDY DESIGN AND METHODS: A retrospective review ...
Full textLink to itemCite
Journal ArticleJ Thromb Haemost · December 2004
The natural history of heparin-induced thrombocytopenia (HIT) in the absence of thrombosis was previously established using functional assays for confirmation of diagnosis (e.g. 14C serotonin release assay). An enzyme-linked immunosorbent assay (ELISA) tha ...
Full textLink to itemCite
Journal ArticleTransfusion · November 2004
BACKGROUND: Recombinant activated factor VII (rFVIIa) is being tested to improve hemostasis in a variety of bleeding disorders. Clinical indications and efficacy are still being evaluated for this product. CASE REPORT: Over a 17-month period, rFVIIa was us ...
Full textLink to itemCite
Journal ArticleMod Pathol · April 2004
We conducted this retrospective study to evaluate the relationship between symptoms, histological findings, and treatment of collagenous (CC) and lymphocytic colitis (LC). We identified 19 CC and 12 LC patients having multiple colonoscopic procedures with ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · November 2002
Collagenous colitis (CC) and lymphocytic colitis (LC) are clinical syndromes characterized by the presence of chronic watery diarrhea, few or no endoscopic abnormalities and biopsies that typically show normal crypt architecture, increased mononuclear infl ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · November 2002
Lymphocytic colitis (LC) and collagenous colitis (CC) are diseases characterized by the presence of marked intraepithelial lymphocytosis. Both of these disorders affect primarily the colon. However, involvement of the distal small intestine has not been sy ...
Full textLink to itemCite
Journal ArticleMod Pathol · June 2001
Orthotopic liver transplantation, by eliminating the major site of amyloidogenic protein synthesis, is currently the only definitive treatment of most hereditary amyloidoses. Because of the minimal parenchymal involvement, the explanted livers from familia ...
Full textLink to itemCite
Journal ArticleHum Pathol · January 2000
Familial amyloidotic polyneuropathy (FAP), a hereditary form of systemic amyloidosis with clinically significant neuropathy and cardiomyopathy, is caused by a genetic defect of the transthyretin gene, which is mostly synthesized in the liver. Orthotopic li ...
Full textLink to itemCite